Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stem Cell Research

  Free Subscription


Articles published in Leuk Res

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    November 2017
  1. LEON-RODRIGUEZ E, Rivera-Franco MM, Gomez-Martin D, Romo-Tena J, et al
    Differential T cell subsets and cytokine profile between steady-state and G-CSF-primed bone marrow and its association with graft-versus-host disease.
    Leuk Res. 2017;63:47-52.
    PubMed     Text format     Abstract available


    October 2017
  2. OZDOGAN H, Gur Dedeoglu B, Oztemur Islakoglu Y, Aydos A, et al
    DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Leuk Res. 2017;63:62-71.
    PubMed     Text format     Abstract available


  3. CANDONI A, De Marchi F, Zannier ME, Lazzarotto D, et al
    High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Leuk Res. 2017;63:22-27.
    PubMed     Text format     Abstract available


    September 2017
  4. AZUMA K, Umezu T, Imanishi S, Asano M, et al
    Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.
    Leuk Res. 2017;62:23-28.
    PubMed     Text format     Abstract available


  5. OU R, Huang J, Shen H, Liu Z, et al
    Transcriptome analysis of CD34+ cells from myelodysplastic syndrome patients.
    Leuk Res. 2017;62:40-50.
    PubMed     Text format     Abstract available


    July 2017
  6. AGGOUNE D, Sorel N, Bonnet ML, Goujon JM, et al
    Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs).
    Leuk Res. 2017;60:94-102.
    PubMed     Text format     Abstract available


  7. YANG H, Zheng Y, Zhang Y, Cao Z, et al
    Mesenchymal stem cells derived from multiple myeloma patients protect against chemotherapy through autophagy-dependent activation of NF-kappaB signaling.
    Leuk Res. 2017;60:82-88.
    PubMed     Text format     Abstract available


    June 2017
  8. CHEN H, Liu KY, Xu LP, Chen YH, et al
    Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.
    Leuk Res. 2017;59:136-141.
    PubMed     Text format     Abstract available


    May 2017
  9. GU B, Wu X, Chen G, Ma X, et al
    Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Leuk Res. 2017;59:41-46.
    PubMed     Text format     Abstract available


  10. TAN J, Wang Y, Yu SJ, Ma YY, et al
    Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia.
    Leuk Res. 2017;59:1-7.
    PubMed     Text format     Abstract available


    April 2017
  11. MEDINGER M, Zeiter D, Heim D, Halter J, et al
    Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Leuk Res. 2017;58:43-47.
    PubMed     Text format     Abstract available


    March 2017
  12. GONZALEZ-VICENT M, Molina B, Deltoro N, Sevilla J, et al
    Donor age matters in T-cell depleted haploidentical hematopoietic stem cell transplantation in pediatric patients: Faster immune reconstitution using younger donors.
    Leuk Res. 2017;57:60-64.
    PubMed     Text format     Abstract available


    February 2017
  13. GAO L, Liu J, Zhang Y, Chen X, et al
    Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.
    Leuk Res. 2017;57:27-36.
    PubMed     Text format     Abstract available


  14. ZHAO P, Chen Y, Yue Z, Yuan Y, et al
    Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway.
    Leuk Res. 2017;57:20-26.
    PubMed     Text format     Abstract available


  15. ZEIDAN AM, Battiwalla M, Berlyne D, Winkler T, et al
    Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016.
    Leuk Res. 2017;53:8-12.
    PubMed     Text format     Abstract available


    January 2017
  16. YAO J, Zhang G, Liang C, Li G, et al
    Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary acute myeloid leukemia in first remission.
    Leuk Res. 2017;55:97-104.
    PubMed     Text format     Abstract available


  17. DING L, Zhu H, Yang Y, Yan HM, et al
    The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantation.
    Leuk Res. 2017;56:13-20.
    PubMed     Text format     Abstract available


  18. DROKOV MY, Davydova JO, Kuzmina LA, Galtseva IV, et al
    Level of Granzyme B-positive T-regulatory cells is a strong predictor biomarker of acute Graft-versus-host disease after day +30 after allo-HSCT.
    Leuk Res. 2017;54:25-29.
    PubMed     Text format     Abstract available


  19. WANG L, Raffoux E, Thomas X, Yakoub-Agha I, et al
    Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA.
    Leuk Res. 2017;54:12-16.
    PubMed     Text format     Abstract available


    December 2016
  20. LAZZAROTTO D, Candoni A, Fili C, Forghieri F, et al
    Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.
    Leuk Res. 2016;53:74-81.
    PubMed     Text format     Abstract available


  21. HEINI AD, Berger MD, Seipel K, Taleghani BM, et al
    Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years.
    Leuk Res. 2016;53:28-34.
    PubMed     Text format     Abstract available


    November 2016
  22. CHAVEZ-GONZALEZ A, Centeno-Llanos S, Moreno-Lorenzana D, Sandoval-Esquivel MA, et al
    Casiopeina III-Ea, a copper-containing small molecule, inhibits the in vitro growth of primitive hematopoietic cells from chronic myeloid leukemia.
    Leuk Res. 2016;52:8-19.
    PubMed     Text format     Abstract available


    July 2016
  23. GHOBADI A, Choi J, Fiala MA, Fletcher T, et al
    Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.
    Leuk Res. 2016;49:1-6.
    PubMed     Text format     Abstract available


    June 2016
  24. LUO Y, Zeng HQ, Shen Y, Zhang P, et al
    Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies.
    Leuk Res. 2016;48:6-10.
    PubMed     Text format     Abstract available


  25. SAITO B, Hattori N, Yamamoto K, Arai N, et al
    Umbilical cord blood transplantation for adults using tacrolimus with two-day very-short-term methotrexate for graft-versus-host disease prophylaxis.
    Leuk Res. 2016;47:161-165.
    PubMed     Text format     Abstract available


    May 2016
  26. TOMASIUK R, Gawronski K, Rzepecki P, Rabijewski M, et al
    The evaluation of NT-proCNP, C-reactive protein and serum amyloid A protein concentration in patients with multiple myeloma undergoing stem cell transplantation.
    Leuk Res. 2016;47:123-127.
    PubMed     Text format     Abstract available


  27. CHATTERJEE R, Chattopadhyay S, Law S
    Alteration of classical and hematopoiesis specific p53 pathway in the bone marrow hematopoietic stem/progenitor compartment facilitates leukemia progression in experimental mice.
    Leuk Res. 2016;47:70-77.
    PubMed     Text format     Abstract available


  28. WANG J, Hu J, Jin Z, Wan H, et al
    The sensitivity of chronic myeloid leukemia CD34 cells to Bcr-Abl tyrosine kinase inhibitors is modulated by ceramide levels.
    Leuk Res. 2016;47:32-40.
    PubMed     Text format     Abstract available


  29. MEDINGER M, Heim D, Gerull S, Halter J, et al
    Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Leuk Res. 2016;47:22-25.
    PubMed     Text format     Abstract available


    April 2016
  30. KOUVIDI E, Stratigi A, Batsali A, Mavroudi I, et al
    Cytogenetic evaluation of mesenchymal stem/stromal cells from patients with myelodysplastic syndromes at different time-points during ex vivo expansion.
    Leuk Res. 2016;43:24-32.
    PubMed     Text format     Abstract available


    March 2016
  31. CARRETT-DIAS M, Almeida LK, Pereira JL, Almeida DV, et al
    Cell differentiation and the multiple drug resistance phenotype in human erythroleukemic cells.
    Leuk Res. 2016;42:13-20.
    PubMed     Text format     Abstract available


    January 2016
  32. TEOH HK, Chong PP, Abdullah M, Sekawi Z, et al
    Small interfering RNA silencing of interleukin-6 in mesenchymal stromal cells inhibits multiple myeloma cell growth.
    Leuk Res. 2016;40:44-53.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: